Rilpivirine

From WikiMD.org
Jump to navigation Jump to search

Rilpivirine

Rilpivirine (pronounced ril-pi-vi-rine) is an antiretroviral medication used in the treatment of HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is marketed under the brand names Edurant and Odefsey.

Etymology

The name "Rilpivirine" is derived from the chemical structure of the drug. The prefix "Ril-" is an abbreviation of the chemical group "aryl", "piv-" is derived from "piperidine", and "-irine" is a common suffix for NNRTIs.

Usage

Rilpivirine is used in combination with other antiretroviral medications to treat HIV-1 infection in adults and children who are at least 12 years old and weigh at least 35 kilograms. It is not a cure for HIV or AIDS, but it can help keep HIV under control and reduce the risk of developing illnesses associated with the disease.

Side Effects

Common side effects of Rilpivirine include depression, insomnia, headache, and rash. Serious side effects may include liver problems, mood changes, and changes in the immune system (immune reconstitution syndrome).

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski